Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Curis, Inc. - Common Stock (NQ:CRIS)

1.479 -0.041 (-2.72%)
Streaming Delayed Price Updated: 3:03 PM EDT, Oct 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Curis, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2021
Upgrades DA Davidson upgraded the previous rating for Columbia Banking System Inc (NASDAQ: 
Via Benzinga
Why Curis Stock Perked Up in August
The biotech's shares rode the wave of buyout speculation higher last month. 
Via The Motley Fool
Curis, Inc. (NASDAQ:CRIS) Investor Alert: Investigation over Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 08/24/2021 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Curis, Inc. 
Via SBWire
Return on Capital Employed Overview: Curis
Pulled from Benzinga Pro data Curis (NASDAQ:CRIS) reported Q2 sales of $2.29 million. Earnings fell to a loss of $10.65 million, resulting in a 21.02% decrease from last quarter.... 
Via Benzinga
Curis (CRIS) Q2 2021 Earnings Call Transcript
CRIS earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Recap: Curis Q2 Earnings
Shares of Curis (NASDAQ:CRIS) were flat in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 29.41% year over year to... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Dare Bioscience (NASDAQ:DARE) sto... 
Via Benzinga
Analyzing Curis's Unusual Options Activity
Shares of Curis (NASDAQ:CRIS) saw some unusual options activity on Thursday. Following the unusual option alert, the stock price moved up to $7.66. Sentiment: BULLISH Option... 
Via Benzinga
NASDAQ:CRIS Investor Notice: Investigation over Possible Securities Laws Violations by Curis, Inc.
San Diego, CA -- (SBWIRE) -- 07/07/2021 -- Curis, Inc. is under investigation over potential securities laws violations by Curis, Inc. in connection with certain financial statements. 
Via SBWire
Kymera Therapeutics' KT-413 Shows Encouraging Preclinical Anti-Cancer Activity
Kymera Therapeutics Inc (NASDAQ: KYMR) has announced new preclinical data on its IRAKIMiD degrader KT-413's potential as both a monotherapy and in combination... 
Via Benzinga
64 Biggest Movers From Friday
Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares gained... 
Via Benzinga
Topics Initial Public Offering
Why Curis Fell Off a Cliff on Friday
The company will bring a lower dose of an important pipeline drug into a phase 2 clinical trial. 
Via The Motley Fool
Mid-Afternoon Market Update: Crude Oil Rises 1%; Janux Therapeutics Shares Jump
Toward the end of trading Friday, the Dow traded down 0.1% to 34,432.88 while the NASDAQ rose 0.16% to 14,043.26. The S&P also rose, gaining 0.04% to 4,240.72. The U.S. has... 
Via Benzinga
Topics Stocks
46 Stocks Moving In Friday's Mid-Day Session
Gainers Kanzhun Limited (NASDAQ: BZ) shares surged 77.4% to $33.70 after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares jumped 73.3% to $15.67... 
Via Benzinga
Topics Initial Public Offering
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Novan (NASDAQ:NOVN) stock rose 71.04% to $15.46 during Friday's regular session. As of 12:30 EST, Novan's stock is trading at a volume of 109.3 million,... 
Via Benzinga
Mid-Day Market Update: Markets Mixed; Novan Shares Spike Higher
Midway through trading Friday, the Dow traded down 0.07% to 34,442.46 while the NASDAQ rose 0.09% to 14,033.42. The S&P also rose, gaining 0.01% to 4,239.73. The U.S. has the... 
Via Benzinga
Topics Stocks
Curis Shares Drop After Updated CA-4948 Data From Mid-Stage Blood Cancer Trial
Curis Inc (NASDAQ: CRIS) has announced updated data from its ongoing Phase 1/2 study of CA-4948 in patients with acute myeloid leukemia (AML) or high-risk... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers GBS (NASDAQ:GBS) stock increased by 41.04% to $5.12 during Friday's pre-market session. Novan (NASDAQ:NOVN) stock increased by 36.5% to $12.34. The company... 
Via Benzinga
The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10) Alexion Pharmaceuticals,... 
Via Benzinga
Why Curis Stock Crashed on Thursday
The swoon came shortly after some very good news for the company. 
Via The Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers MultiPlan (NYSE:MPLN) stock increased by 17.31% to $7.21 during Thursday's regular session. Trading volume for MultiPlan's stock is 4.0 million as of 12:30... 
Via Benzinga
The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck
Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,... 
Via Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
Gainers Reliance Global Group, Inc. (NASDAQ: RELI) jumped 38.7% to $4.0901 after the company said it has acquired a premier health insurance agency, J.P. Kush and Associates, Inc... 
Via Benzinga
77 Biggest Movers From Yesterday
Gainers AMC Entertainment Holdings, Inc. (NYSE: AMC) shares surged 23.7% to close at $12.77. Moxian, Inc. (NASDAQ: MOXC) jumped 23.6% to close at $9.52. Repro Med Systems, Inc... 
Via Benzinga
Curis Stock Is On A Wild Ride — What Spooked Investors After A 65% Surge
Curis is taking investors on a wild ride. After rocketing on a promising blood-cancer drug on Wednesday, CRIS stock plummeted Thursday. 
Via Investor's Business Daily
Curis Shares Drop On Safety Issues From Leukemia Study With CA-4948; Q1 Earnings Missing Estimates
Curis Inc (NASDAQ: CRIS) stock gained momentum yesterday in reaction to updated data from its Phase 1/2 study of CA-4948 in patients with acute myeloid... 
Via Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Palisade Bio (NASDAQ:PALI) shares moved upwards by 35.23% to $7.1 during Thursday's pre-market session. Lianluo Smart (NASDAQ:LLIT) shares rose 19.37% to $7.21... 
Via Benzinga
26 Stocks Moving in Thursday's Pre-Market Session
Gainers Fuel Tech, Inc. (NASDAQ: FTEK) shares rose 26.3% to $2.45 in pre-market trading after the company reported upbeat results for its first quarter on Wednesday. Celyad... 
Via Benzinga
62 Biggest Movers From Yesterday
Gainers Curis, Inc. (NASDAQ: CRIS) shares surged 65.5% to settle at $16.27 on Wednesday in reaction to updated data from its ongoing open-label, single-arm, Phase 1/2 study of CA... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.